Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 4/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | CCR1 | P32246 | 2/20 | 0.54 |
| ▸ | CCR5 | P51681 | 2/20 | 0.54 |
| ▸ | CCR8 | P51685 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | METAP1 | P53582 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.54 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.52 |
| ▸ | HTT | P42858 | 4/20 | 0.52 |
| ▸ | ALPL | P05186 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29913760 | 1.00 | KDM4E (1.00) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| SCHEMBL4331114 | 0.96 | KDM4E (0.92) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| Dipyridyl SCHEMBL29167113 | 0.89 | KDM4E (0.79) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| SCHEMBL1704624 | 0.87 | KDM4E (0.76) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| SCHEMBL19445116 | 0.87 | KDM4E (0.76) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| SCHEMBL5848140 | 0.84 | KDM4E (0.71) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| SCHEMBL322756 | 0.84 | KDM4E (1.00) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| SCHEMBL29354466 | 0.84 | KDM4E (1.00) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| SCHEMBL1704219 | 0.82 | KDM4E (0.69) | KDM4EL3MBTL1ALOX15TDP1TP53 | |
| SCHEMBL30818096 | 0.82 | KDM4E (0.69) | KDM4EL3MBTL1ALOX15TDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113122872-B | Cobalt and nitrogen doped carbon nanotube/carbon electrocatalyst and preparation method and application thereof | 合肥工业大学 | 2022-07-12 | — | — | CN | claimed |
| CN-113122872-A | Cobalt and nitrogen doped carbon nanotube/carbon electrocatalyst and preparation method and application thereof | 合肥工业大学 | 2021-07-16 | — | — | CN | claimed |
| US-4501689-A | CONTAINING PYRIDINE OR IMIDAZOLE MODIFIED 5-TRIAZINE | TAMURA KAKEN CO., LTD. (JP) | 1985-02-26 | — | — | US | claimed |
| CN-117624137-A | Triazine skeleton small molecule heparin reversal agent and preparation method and application thereof | 中国药科大学 | 2024-03-01 | — | — | CN | disclosed |
| CN-117529476-A | Preparation of substituted 1, 2-diamino heterocyclic derivatives and their use as medicaments | 亚飞络思制药公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-113122872-B | Cobalt and nitrogen doped carbon nanotube/carbon electrocatalyst and preparation method and application thereof | 合肥工业大学 | 2022-07-12 | — | — | CN | disclosed |
| CN-113122872-B | Cobalt and nitrogen doped carbon nanotube/carbon electrocatalyst and preparation method and application thereof | 合肥工业大学 | 2022-07-12 | — | — | CN | disclosed |
| CN-113122872-A | Cobalt and nitrogen doped carbon nanotube/carbon electrocatalyst and preparation method and application thereof | 合肥工业大学 | 2021-07-16 | — | — | CN | disclosed |
| CN-113122872-A | Cobalt and nitrogen doped carbon nanotube/carbon electrocatalyst and preparation method and application thereof | 合肥工业大学 | 2021-07-16 | — | — | CN | disclosed |
| US-9573117-B2 | Catalyst precursors, catalysts and methods of producing same | INSTITUTE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2017-02-21 | — | — | US | disclosed |
| CN-105555779-A | Herbicidal azines | BASF SE | 2016-05-04 | — | — | CN | disclosed |
| EP-2673084-A1 | CATALYSTS MADE USING THERMALLY DECOMPOSABLE POROUS SUPPORTS | Institut National De La Recherche Scientifique (CA) | 2013-12-18 | — | — | EP | disclosed |
| US-8580704-B2 | Catalyst precursors, catalysts and methods of producing same | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2013-11-12 | — | — | US | disclosed |
| WO-2012107838-A1 | CATALYSTS MADE USING THERMALLY DECOMPOSABLE POROUS SUPPORTS | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2012-08-16 | — | — | WO | disclosed |
| US-20110294658-A1 | CATALYST PRECURSORS, CATALYSTS AND METHODS OF PRODUCING SAME | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2011-12-01 | — | — | US | disclosed |
| US-20110124649-A1 | INHIBITORS OF HUMAN METHIONINE AMINOPEPTIDASE 1 AND METHODS OF TREATING DISORDERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-05-26 | — | — | US | disclosed |
| US-20110124649-A1 | INHIBITORS OF HUMAN METHIONINE AMINOPEPTIDASE 1 AND METHODS OF TREATING DISORDERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-05-26 | — | — | US | disclosed |
| WO-2010051619-A1 | CATALYST PRECURSORS, CATALYSTS AND METHODS OF PRODUCING SAME | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2010-05-14 | — | — | WO | disclosed |
| WO-2009064388-A2 | INHIBITORS OF HUMAN METHIONINE AMINOPEPTIDASE 1 AND METHODS OF TREATING DISORDERS | LIU JUN O (US) | 2009-05-22 | — | — | WO | disclosed |
| US-4501689-A | CONTAINING PYRIDINE OR IMIDAZOLE MODIFIED 5-TRIAZINE | TAMURA KAKEN CO., LTD. (JP) | 1985-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124649-A1 | INHIBITORS OF HUMAN METHIONINE AMINOPEPTIDASE 1 AND METHODS OF TREATING DISORDERS | METAP1, DNPEP, METAP2 | KDM4E 2936/4885L3MBTL1 973/4885ALOX15 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.